Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 17/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 8/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SCN1A | P35498 | 1/20 | 0.36 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.36 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11006192 | 0.83 | CYP19A1 (0.43) | CYP19A1CYP17A1TDP1SCN1ASCN2A | |
| SCHEMBL13442374 | 0.81 | CYP19A1 (0.42) | CYP19A1CYP17A1TDP1SCN1ASCN2A | |
| SCHEMBL1439686 | 0.77 | CYP19A1 (0.50) | CYP19A1CYP17A1TDP1SCN1ASCN2A | |
| SCHEMBL23439845 | 0.76 | CYP19A1 (0.40) | CYP19A1CYP17A1TDP1SCN1ASCN2A | |
| SCHEMBL13408312 | 0.76 | CYP19A1 (0.45) | CYP19A1CYP17A1TDP1SCN1ASCN2A | |
| SCHEMBL25371917 | 0.75 | CYP19A1 (0.45) | CYP19A1CYP17A1TDP1SCN1ASCN2A | |
| SCHEMBL25371913 | 0.75 | CYP19A1 (0.45) | CYP19A1CYP17A1TDP1SCN1ASCN2A | |
| SCHEMBL4586180 | 0.75 | CYP19A1 (0.42) | CYP19A1CYP17A1TDP1SCN9A | |
| SCHEMBL24133068 | 0.75 | CYP19A1 (0.45) | CYP19A1CYP17A1TDP1SCN1ASCN2A | |
| SCHEMBL13840075 | 0.74 | CYP19A1 (0.39) | CYP19A1CYP17A1TDP1SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0915699-A4 | STEREOSELECTIVE SYNTHESIS OF ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2008-06-25 | — | — | EP | claimed |
| EP-0915699-A1 | STEREOSELECTIVE SYNTHESIS OF ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-05-19 | — | — | EP | claimed |
| WO-1997017071-A1 | STEREOSELECTIVE SYNTHESIS OF ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-15 | — | — | WO | claimed |
| EP-0330756-B1 | Thienotricyclics for the treatment of bronchial diseases | BYK GULDEN LOMBERG CHEM FAB (DE) | 1996-03-27 | — | — | EP | claimed |
| US-5140025-A | Telenzepine, ie, 4,9-dihydro-3-methyl-4-((4-methyl-1-piperazinyl)-acetyl)-1OH-thieno(3,4 -b)(1,5)-benzodiazepine | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1992-08-18 | — | — | US | claimed |
| WO-1991011449-A1 | PROCESS FOR THE PRODUCTION OF THIENOTRICYCLENE | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1991-08-08 | — | — | WO | claimed |
| EP-0915699-A4 | STEREOSELECTIVE SYNTHESIS OF ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2008-06-25 | — | — | EP | disclosed |
| US-6162932-A | Stereoselective synthesis of endothelin receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2000-12-19 | — | — | US | disclosed |
| US-6080862-A | PREPARING (1S, 2R, 3S)-3-(2-HYDROXYETH-1-YLOXY)-4-METHOXYPHENYL) 1-(3,4-METHYLENEDIOXYPHENYL) 5-(PROP-1-YLOXY)INDANE-2-CARBOXYLIC ACID | SMITHKLINE BEECHAM CORPORATION (US) | 2000-06-27 | — | — | US | disclosed |
| EP-0915699-A1 | STEREOSELECTIVE SYNTHESIS OF ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-05-19 | — | — | EP | disclosed |
| WO-1997017071-A1 | STEREOSELECTIVE SYNTHESIS OF ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-15 | — | — | WO | disclosed |
| US-5140025-A | Telenzepine, ie, 4,9-dihydro-3-methyl-4-((4-methyl-1-piperazinyl)-acetyl)-1OH-thieno(3,4 -b)(1,5)-benzodiazepine | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1992-08-18 | — | — | US | disclosed |